Success Story
RAPA achieves research allowance success with innoscripta
Reduced internal effort
Clear path through bureaucracy
Industry
Motor Vehicle Manufacturing, Industrial Technology, Healthcare
Company Size
Large Enterprise
Location
Selb, Germany
“The topic of research allowances initially raised many questions for us. The complexity of the application process honestly put us off. innoscripta showed us that funding doesn't have to be a bureaucratic nightmare.”
Meet RAPA
RAPA is a family owned company with an established tradition and strong futuristic mindset. Founded in 1920 in Selb, the company started as a small workshop and has since evolved into an internationally active business group. In 2020, RAPA introduced a new company structure where RAPA SE acts as the holding company and handles central tasks such as IT infrastructure and finance. Their subsidiaries include RAPA Automotive, RAPA Healthcare, and RAPA Industry. Each subsidiary is led by its own managing directors and operates independently in the market.
Headquartered in Selb, RAPA integrates administration, production, and logistics at a 45,000 square-metre site. Their additional international locations are based in North America and China. With nearly 1,000 employees worldwide, a strong commitment to R&D, and a diversified range of services, RAPA has positioned itself as a technology and engineering partner. Certified under EMAS and ISO 14001, the company integrates sustainability and innovations into their long-term strategy.
The Challenge
RAPA faced significant internal concerns regarding the processing of its research grant applications, as these are highly specific, adhere strictly to the specified guidelines, and are perceived as bureaucratic. Due to the technical complexities of their projects, they assumed the need for massive internal efforts to navigate the process.
The Solution
innoscripta has provided RAPA with comprehensive support and a high level of technical expertise since the beginning of their collaboration. innoscripta's team showed exceptional ability to quickly absorb and understand RAPA's complex product concepts. Their expertise minimised the internal efforts from RAPA's team significantly and innoscripta's software enabled a user-friendly overall process.
The Impact
The collaboration with innoscripta resulted in substantial values for RAPA, which are efficient and profitable. RAPA achieved financial support for their R&D projects under the research allowance and was able to save a remarkable amount of time, which supported them to focus on accelerated R&D efforts.
